Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis.
Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).
Subcortical White Matter Changes with Normal Aging Detected by Multi-Shot High Resolution Diffusion Tensor Imaging.
Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity.
Vitamin D level status in Thai neuromyelitis optica patients.
Restriction spectrum imaging reveals decreased neurite density in patients with temporal lobe epilepsy.
Expression of switch-associated protein 70 is associated with lymphocyte activation and reduced disability in multiple sclerosis.
Epigenetic control of oligodendrocyte development: adding new players to old keepers.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Increased Sleep Depth in Developing Neural Networks: New Insights from Sleep Restriction in Children.
SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
[Response to treatment with interferon beta in patients with multiple sclerosis. Validation of the Rio Score].
Coactivation of Lower Limb Muscles during Gait in Patients with Multiple Sclerosis.
PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells.
Air pollution, a rising environmental risk factor for cognition, neuroinflammation and neurodegeneration: The clinical impact on children and beyond.
T1 relaxometry of crossing fibres in the human brain.
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.
Unilateral olfactory sensitivity in multiple sclerosis.
Effects of Proton and Combined Proton and (56)Fe Radiation on the Hippocampus.
Evaluation of Handwriting Movement Kinematics: From an Ecological to a Magnetic Resonance Environment.
Allelic variations in rat MHC class II binding of myelin basic protein peptides correlate with encephalitogenicity.
Effect of Platelet-Rich Fibrin on Peripheral Nerve Regeneration.
Progressive Multifocal Leukoencephalopathy Localized in the Cerebellum and Brainstem Associated with Idiopathic CD4(+) T Lymphocytopenia.
Mapping Variation in Cellular and Transcriptional Response to 1,25-Dihydroxyvitamin D3 in Peripheral Blood Mononuclear Cells.
The effects of mechanical focal vibration on walking impairment in multiple sclerosis patients: A randomized, double-blinded vs placebo study.
Pages
« first
‹ previous
…
711
712
713
714
715
716
717
718
719
…
next ›
last »